OrganizationsETH Zurich

Products 1 to 1 of 1

Cellular Implant for Detection of Hypercalcemia Associated with Cancer by ETH Zurich
Biotech components: Gene Editing
Business models: B2C
Country of production: Switzerland
Country of distribution: Switzerland
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/08 14:47 (6 years ago)
Known funding amount: N/A
Funding types: Government
Industry: Health
Market status: Early Stage Concept
Organization type(s): Research Institution + University
Product categories: Medical Treatment
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product